Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,164 | -40,000 | -65,890 | -50,194 | -32,988 |
| Depreciation Amortization | 9,227 | 4,537 | 18,417 | 13,783 | 9,370 |
| Accounts receivable | -12,834 | 2,569 | -1,852 | -5,792 | -4,342 |
| Accounts payable and accrued liabilities | -3,005 | 1,288 | -581 | N/A | N/A |
| Other Working Capital | -17,114 | -296 | -18,745 | -24,531 | -24,683 |
| Other Operating Activity | 27,656 | 6,494 | -7,550 | 3,143 | 525 |
| Operating Cash Flow | $-58,234 | $-25,408 | $-76,201 | $-63,591 | $-52,118 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -280,721 | -149,034 | -164,835 | -140,688 | -61,030 |
| PPE Investments | -13,986 | -7,487 | -18,654 | -10,536 | -5,910 |
| Purchase Of Investment | -28 | -28 | -14,492 | N/A | N/A |
| Sale Of Investment | 140,978 | 12,470 | 192,401 | 135,983 | 102,575 |
| Investing Cash Flow | $-153,757 | $-144,079 | $-5,580 | $-15,241 | $35,635 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 118,463 | 113,383 | 98,550 |
| Debt Repayment | -1,788 | -1,001 | -19,717 | -19,481 | -17,031 |
| Common Stock Issued | 204,459 | 202,216 | 2,554 | 1,448 | 481 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -200 |
| Financing Cash Flow | $202,671 | $201,215 | $101,300 | $95,350 | $81,800 |
| Beginning Cash Position | 44,446 | 44,446 | 24,927 | 34,879 | 34,879 |
| End Cash Position | 35,126 | 76,174 | 44,446 | 51,397 | 100,196 |
| Net Cash Flow | $-9,320 | $31,728 | $19,519 | $16,518 | $65,317 |
| Free Cash Flow | |||||
| Operating Cash Flow | -58,234 | -25,408 | -76,201 | -63,591 | -52,118 |
| Capital Expenditure | -14,028 | -7,487 | -18,746 | -10,690 | -6,085 |
| Free Cash Flow | -72,262 | -32,895 | -94,947 | -74,281 | -58,203 |